Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Poly(exTTF): a novel redox-active polymer as active material for li-organic batteries.

Häupler B, Burges R, Friebe C, Janoschka T, Schmidt D, Wild A, Schubert US.

Macromol Rapid Commun. 2014 Aug;35(15):1367-71. doi: 10.1002/marc.201400167. Epub 2014 May 23.

PMID:
24861014
2.

The Genotype-Tissue Expression (GTEx) project.

GTEx Consortium.

Nat Genet. 2013 Jun;45(6):580-5. doi: 10.1038/ng.2653.

3.

HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls.

Lyke KE, Burges RB, Cissoko Y, Sangare L, Kone A, Dao M, Diarra I, Fernández-Vina MA, Plowe CV, Doumbo OK, Sztein MB.

Infect Immun. 2005 Sep;73(9):5799-808.

5.

Unique pharmacologic properties of amlodipine.

Burges R, Moisey D.

Am J Cardiol. 1994 Jan 27;73(3):2A-9A. Review.

PMID:
8310972
6.

Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs.

Gwilt M, Blackburn KJ, Burges RA, Higgins AJ, Milne AA, Solca AM.

Eur J Pharmacol. 1992 May 14;215(2-3):137-44.

PMID:
1396982
7.

Amlodipine: a once daily calcium antagonist.

Burges RA.

J Hum Hypertens. 1991 Aug;5 Suppl 1:49-54. Review.

PMID:
1834846
8.

Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent.

Gwilt M, Dalrymple HW, Burges RA, Blackburn KJ, Dickinson RP, Cross PE, Higgins AJ.

J Cardiovasc Pharmacol. 1991 Mar;17(3):376-85.

PMID:
1711597
9.

UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.

Gwilt M, Arrowsmith JE, Blackburn KJ, Burges RA, Cross PE, Dalrymple HW, Higgins AJ.

J Pharmacol Exp Ther. 1991 Jan;256(1):318-24.

PMID:
1988662
10.

The pharmacological profile of amlodipine in relation to ischaemic heart disease.

Burges RA.

Postgrad Med J. 1991;67 Suppl 3:S9-15. Review.

PMID:
1836872
12.

Selective class III antiarrhythmic agents. 1 Bis(arylalkyl)amines.

Cross PE, Arrowsmith JE, Thomas GN, Gwilt M, Burges RA, Higgins AJ.

J Med Chem. 1990 Apr;33(4):1151-5.

PMID:
2319561
14.

Pharmacologic profile of amlodipine.

Burges RA, Dodd MG, Gardiner DG.

Am J Cardiol. 1989 Nov 7;64(17):10I-18I; discussion 18I-20I. Review.

PMID:
2554708
15.
16.

The hemodynamic properties of amlodipine in anesthetised and conscious dogs: comparison with nitrendipine and influence of beta-adrenergic blockade.

Dodd MG, Gardiner DG, Carter AJ, Sutton MR, Burges RA.

Cardiovasc Drugs Ther. 1989 Aug;3(4):545-55.

PMID:
2577312
17.

Long acting dihydropyridine calcium antagonists. 2. 2-[2-Aminoheterocycloethoxy]methyl derivatives.

Arrowsmith JE, Campbell SF, Cross PE, Burges RA, Gardiner DG.

J Med Chem. 1989 Mar;32(3):562-8.

PMID:
2918502
18.

Natriuretic activity of amlodipine, diltiazem, and nitrendipine in saline-loaded anesthetized dogs.

Carter AJ, Gardiner DG, Burges RA.

J Cardiovasc Pharmacol. 1988;12 Suppl 7:S34-8.

PMID:
2467125
19.

Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.

Burges RA, Gardiner DG, Gwilt M, Higgins AJ, Blackburn KJ, Campbell SF, Cross PE, Stubbs JK.

J Cardiovasc Pharmacol. 1987 Jan;9(1):110-9.

PMID:
2434785
20.

Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents.

Arrowsmith JE, Campbell SF, Cross PE, Stubbs JK, Burges RA, Gardiner DG, Blackburn KJ.

J Med Chem. 1986 Sep;29(9):1696-702.

PMID:
2943898
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk